Biotech | December 30, 2021
Tan Thanh Holdings to pre-purchase 10 million doses of Covid-19 oral vaccines for ASEAN region
Oravax's oral VLP vaccine in development targets three SARS CoV-2 virus surface proteins, including proteins less susceptible to mutation, thus making the vaccine potentially more effective against current and future variants of the Covid-19 virus
_256_275.jpg)